Bristol Myers Squibb Collaboration Octant also recently announced a collaboration with Bristol Myers Squibb. Under the collaboration agreement, Octant will apply its DMS technologies to a set of inflammation-related pathways. Senior Leadership Appointments As Chief Scientific Officer, Rick Artis is going to be responsible for Octant's chemistry function and drug discovery and development programs. Prior to joining Octant in December 2021, he served as a Senior Vice President, Chemistry for Annexon Biosciences, where he led the efforts to develop small molecule inhibitors. Artis also served as the President and CSO of Chorum Pharmaceuticals for over 7 years where he helped develop new opportunities through research collaborations with prominent academic groups in diverse therapeutic areas. Before that, he led Molecular Discovery at Elan where he was responsible for medicinal chemistry, early process chemistry and formulation, assay development and screening, informatics, and structural biology.